Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial

✍ Scribed by Crosby, Thomas; Hurt, Christopher N; Falk, Stephen; Gollins, Simon; Mukherjee, Somnath; Staffurth, John; Ray, Ruby; Bashir, Nadim; Bridgewater, John A; Geh, J Ian; Cunningham, David; Blazeby, Jane; Roy, Rajarshi; Maughan, Tim; Griffiths, Gareth

• Book ID: 122264919
• Publisher: The Lancet
• Year: 2013
• Tongue: English
• Weight: 374 KB
• Volume: 14
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/S1470-2045(13)70136-0